Clinical Trials Browser

INDUSTRY × gusacitinib × Dermatologic × Clear all

NCT04416516 2024-04-10

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT03208296 2023-02-06

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Phase 1/2 Suspended

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02550678 2018-06-06

ASN-002-001

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms